Optiver Holding
DYN icon

Optiver Holding’s Dyne Therapeutics DYN Stock Holding History

Optiver Holding’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6K Buy
+747
New +$13.9K ﹤0.01% 1597
2026
Q1 		– Sell
-395
Closed -$7.73K – 2431
2025
Q4 		$7.73K Sell
395
-508
-56% -$9.62K ﹤0.01% 1204
2025
Q3 		$11.4K Buy
903
+150
+20% +$1.71K ﹤0.01% 1214
2025
Q2 		$7.17K Buy
753
+556
+282% +$6.12K ﹤0.01% 1107
2025
Q1 		$2.06K Buy
+197
New +$2.82K ﹤0.01% 1236

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Optiver Holding's DYN Position: Q2 2026 in Review

Optiver Holding opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 747 shares worth $16.6K. The stake represents ﹤0.01% of the portfolio and ranks #1597 among its holdings. This is a return to the name: Optiver Holding previously reported a position in DYN as recently as Q4 2025.

Optiver Holding first reported a position in DYN in Q1 2025 and has held it in 5 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Optiver Holding held 747 shares of Dyne Therapeutics worth $16.6K as of Q2 2026.
  • Dyne Therapeutics was a new Optiver Holding position in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1597 holding.
  • Optiver Holding first reported a position in Dyne Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.